Imago BioSciences, Inc. Proceeds from Stock Options Exercised
Imago BioSciences, Inc. reported Proceeds from Stock Options Exercised of $837.00 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2022-11-09
- Imago BioSciences, Inc. proceeds from stock options exercised for the quarter ending 2022-09-30 was $366.00K, a 3966.67% increase year-over-year.
- Imago BioSciences, Inc. proceeds from stock options exercised for the quarter ending 2022-06-30 was $17.00K.
- Imago BioSciences, Inc. proceeds from stock options exercised for the quarter ending 2022-03-31 was $454.00K.
- Imago BioSciences, Inc. proceeds from stock options exercised for the quarter ending 2021-12-31 was $390.00K.
- Imago BioSciences, Inc. proceeds from stock options exercised for fiscal 2021 was $506.00K, a 1644.83% increase from fiscal 2020.
- Imago BioSciences, Inc. proceeds from stock options exercised for fiscal 2020 was $29.00K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2022-09-30 | $366.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $383.00K derived: sum of 2 quarters · filed 2022-11-09 | $837.00K 10-Q · filed 2022-11-09 | $1.23M derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-06-30 | $17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $471.00K 10-Q · filed 2022-08-12 | $861.00K derived: sum of 3 quarters · filed 2022-08-12 | $870.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-03-31 | $454.00K 10-Q · filed 2022-05-12 | $844.00K derived: sum of 2 quarters · filed 2022-05-12 | $853.00K derived: sum of 3 quarters · filed 2022-11-09 | |
| 2021-12-31 | $390.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $399.00K derived: sum of 2 quarters · filed 2022-11-09 | $506.00K 10-K · filed 2022-03-24 | |
| 2021-09-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $116.00K 10-Q · filed 2022-11-09 | ||
| 2021-06-30 | $107.00K 10-Q · filed 2022-08-12 | |||
| 2020-12-31 | $29.00K 10-K · filed 2022-03-24 |